Article Abstract

Dr. Michael Milano: a better understanding in how radiation interacts with immunotherapy will be a future trend of precision cancer research

Authors: Anne Lu


Dr. Michael Milano has just joined the Editorial Board of Precision Cancer Medicine (PCM, Precis Cancer Med, ISSN: 2617-2216) since August 2018. He has been devoted to pursuing radiation oncology all through his career and treating and caring patients with cancer or benign brain tumors. This time, we are honored to interview Dr. Michael Milano to share with our readers his expertise in radiation oncology, his insights of cancer treatments in the perspective of precision medicine, and his valuable experience during his clinic and research practice.